Common geriatric conditions and disabilities in older persons with chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 17, Issue SUPPL. 1, 2011, Pages

  Landi, Francesco ^a   Pistelli, Riccardo ^a   Abbatecola, Angela M ^b   Barillaro, Christian ^a   Brandi, Vincenzo ^a   Lattanzio, Fabrizia ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b INRCA   (Italy)

Author keywords

aging; cognitive decline; physical disability; respiratory disability

Indexed keywords

ANXIETY DISORDER; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; DEPRESSION; DYSPNEA; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; GERIATRIC DISORDER; HIGH RISK PATIENT; HYPOXIA; MOOD DISORDER; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; QUALITY OF LIFE; RESPIRATORY FAILURE; RISK FACTOR; SHORT PHYSICAL PERFORMANCE BATTERY; SIX MINUTE WALKING TEST; SPIROMETRY; TREADMILL EXERCISE; WALKING;

AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; COMORBIDITY; DEPRESSION; DISEASE PROGRESSION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; GERIATRIC ASSESSMENT; HEALTH STATUS; HUMANS; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SPIROMETRY; VITAL CAPACITY;

EID: 84855397343     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/01.mcp.0000410745.75216.99     Document Type: Article

References (55)

1. Gershon AS, Warner L, Cascagnette P et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 2011; 378:991-996.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765-773. (Pubitemid 47321908)
3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165-1185.
4. Braido F, Baiardini I, Menoni S et al. Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin 2011; 27:981-986.
5. Fabbri LM, Luppi F, Beghe B et al. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204-212.
6. Chatila WM, Thomashow BM, Minai OA et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:549-555. (Pubitemid 351669185)
7. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. Available from http://www.goldcopd.org/guidelines-gold-summary-2011.html.
8. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56:880-887. (Pubitemid 32999838)
9. Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012. (Pubitemid 38269277)
10. Esteban C, Quintana JM, Aburto M et al. The health, activity, dyspnea, obstruction, age, and hospitalization: prognostic score for stable COPD patients. Respir Med 2011; 105:1662-1670.
11. Casanova C, Cote C, de Torres JP et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:591-597. (Pubitemid 40365414)
12. Khanna D, Clements PJ, Furst D.E. et al., Scleroderma Lung Study Group. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 2005; 52:592-600. (Pubitemid 40216324)
13. Arnold SV, Spertus JA, Jones PG et al. The impact of dyspnea on healthrelated quality of life in patients with coronary artery disease: results from the PREMIER registry. Am Heart J 2009; 157:1042-1049.
14. O'Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD. The impact on breathing pattern, dyspnea and ventilator capacity during exercise. Chest 2011 Aug 18 [Epub ahead of print]
15. O'Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008; 105:753-755.
16. O'Donnell DE, Casaburi R, Vincken W et al. INABLE 1 study group. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med 2011; 105:1030-1036.
17. Pellegrino R, Brusasco V. Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J 1997; 10:543-549. (Pubitemid 27112566)
18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117.
19. Cote CG, Pinto-Plata V, Kasprzyk K et al. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007; 132:1778-1785.
20. Casanova C, Cote CG, Marin JM et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007; 29:535-540. (Pubitemid 46372102)
21. Pinto-Plata VM, Cote C, Cabral H et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28-33. (Pubitemid 38088492)
22. Spruit MA, Polkey MI, Celli B et al.; on behalf of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2011 Jul 19 [Epub ahead of print]
23. Guralnik JM, Simonsick EM, Ferrucci L et al. A Short Physical Performance Battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49:M85-94. (Pubitemid 24100267)
24. Guralnik JM, Ferrucci L, Simonsick EM et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332:556-561.
25. Simonsick EM, Newman AB, Nevitt MC et al. Health ABC Study Group. Measuring higher level physical function in well functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci 2001; 56:M644-M649. (Pubitemid 32954233)
26. Abbatecola AM, Cherubini A, Guralnik JM et al. Plasma polyunsaturated fatty acids and age-related physical performance decline. Rejuvenation Res 2009; 12:25-32.
27. Studenski S, Perera S, Wallace D et al. Physical performance measures in the clinical setting. J Am Geriatr Soc 2003; 51:314-322. (Pubitemid 36348892)
28. Volpato S, Cavalieri M, Sioulis F et al. Predictive value of the Short Physical Performance Battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci 2011; 66 (1):89-96.
29. Rolland Y, Lauwers-Cances V, Cesari M et al. Physical performance measures as predictors of mortality in a cohort of community-dwelling older French women. Eur J Epidemiol 2006; 21:113-122. (Pubitemid 43341199)
30. Ostir GV, Volpato S, Fried LP et al. Women's Health and Aging Study. Reliability and sensitivity to change assessed for a summary measure of lower body function: results from the Women's Health and Aging Study. J Clin Epidemiol 2002; 55:916-921. (Pubitemid 35246563)
31. Ilgin D, Ozalevli S, Kilinc O et al. Gait speed as a functional capacity indicator in patients with chronic obstructive pulmonary disease. Ann Thorac Med 2011; 6:141-146.
32. Eisner MD, Blanc PD, Yelin EH et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008; 121:789-796.
33. Rodriguez Gonzalez-Moro JM, de Lucas Ramos P, Izquierdo Alonso JL et al. Impact of COPD severity on physical disability and daily living activities: EDIPEPOC I and EDIP-EPOC II studies. Int J Clin Pract 2009; 63:742-750.
34. Incalzi RA, GemmaA, Marra C et al. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 1993; 148:418-424. (Pubitemid 23221588)
35. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006; 20:99-106.
36. Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 2008; 6:100-118.
37. Lautenschlager NT, Cox KL, Flicker L et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300:1027-1037.
38. Kirkil G, Tug T, Ozel E et al. The evaluation of cognitive functions with P300 test for chronic obstructive pulmonary disease patients in attack and stable period. Clin Neurol Neurosurg 2007; 109:553-560. (Pubitemid 47016751)
39. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited). Respir Care 2000; 45:204-211.
40. Grant I, Heaton RK, Mc Sweeny AJ et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982; 142:1470-1476. (Pubitemid 12048347)
41. Hung W, Wisnivesky JP, Siu AL et al. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180:134-137.
42. Reeves RR, Struve FA, Patrick G et al. Auditory and visual P300 cognitive evoked responses in patients with COPD: relationship to degree of pulmonary impairment. Clin Electroencephalogr 1999; 30:122-125. (Pubitemid 30126126)
43. Thakur N, Blanc PD, Julian LJ et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 2010; 5:263-269.
44. Antonelli-Incalzi R, Corsonello A, Trojano L et al. Screening of cognitive impairment in chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord 2007; 23:264-270. (Pubitemid 46496814)
45. Antonelli-Incalzi R, Corsonello A, Trojano L et al. Correlation between cognitive impairment and dependence in hypoxemic COPD. J Clin Exp Neuropsychol 2008; 30:141-150.
46. National Institute for Clinical Excellence. National clinical guidelines on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59 (Suppl 1):1-232.
47. Norwood RJ. A review of etiologies of depression in COPD. Int J Chron Obstruct Pulmon Dis 2007; 2:485-491.
48. Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol 2000; 10:193-202. (Pubitemid 30598979)
49. Zheng GQ, Wang Y, Wang XT. Chronic hypoxia-hypercapnia influences cognitive function: a possible new model of cognitive dysfunction in chronic obstructive pulmonary disease. Med Hypotheses 2008; 71:111-113.
50. Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med 1998; 92:1231-1236. (Pubitemid 28502366)
51. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment. Psychosom Med 2003; 65:963-970. (Pubitemid 38057795)
52. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability.Gen Hosp Psychiatry 2007; 29:409-416. (Pubitemid 47410305)
53. Felker B, Katon W, Hedrick SC et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 2001; 23:56-61. (Pubitemid 32335573)
54. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res 2007; 63:551-565. (Pubitemid 350007668)
55. von Leupoldt A, Taube K, Lehmann K et al. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011; 140:730-736.